Peroxisome Proliferator Receptor alpha Agonist drugs compared
Compare all 4 Peroxisome Proliferator Receptor alpha Agonist drugs side by side, used for conditions such as coronary artery disease, hypercholesterolemia, hyperlipoproteinemias. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is gemfibrozil.
Top-rated peroxisome proliferator receptor alpha agonist: 1. Gemfibrozil · 2. Lopid · 3. Actos
| Drug | Generic | Form | Status | Used for | Safety ratingFDA recall-based | Pharmacy pays |
|---|---|---|---|---|---|---|
| Gemfibrozil | — | Tablet | Prescription | Coronary Artery Disease, Hypercholesterolemia | 70/100 | $3 |
| Lopid | Gemfibrozil | Tablet | Prescription | Coronary Artery Disease, Hypercholesterolemia | 64/100 | $3 |
| Actos | Pioglitazone Hydrochloride | Tablet | Prescription | Diabetes Mellitus, Type 2 | Not yet rated | $3 |
| Lipofen | Fenofibrate | Capsule | Prescription | Coronary Artery Disease, Hypercholesterolemia | Not yet rated | $3 |
The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.
Best peroxisome proliferator receptor alpha agonist by condition
Full ranking · 4 drugs
- 170/100
gemfibrozil
Gemfibrozil
- 264/100
lopid
Gemfibrozil
- 3New
actos
Pioglitazone Hydrochloride
- 4New
lipofen
Fenofibrate
Frequently asked questions
What is the Peroxisome Proliferator Receptor alpha Agonist drug class?
Peroxisome Proliferator Receptor alpha Agonist is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 4 Peroxisome Proliferator Receptor alpha Agonist products, each independently rated.
Are all Peroxisome Proliferator Receptor alpha Agonist drugs the same?
No. Peroxisome Proliferator Receptor alpha Agonist drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Peroxisome Proliferator Receptor alpha Agonist drugs treat?
Per NIH RxClass drug-classification data, Peroxisome Proliferator Receptor alpha Agonist drugs are used for conditions including coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia, diabetes mellitus, type 2.
Which Peroxisome Proliferator Receptor alpha Agonist drug is best-rated?
By our independent rating, gemfibrozil currently ranks highest among Peroxisome Proliferator Receptor alpha Agonist drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Sources: the Peroxisome Proliferator Receptor alpha Agonist class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.